Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
First Advantage Corporation (FA)
Sprinklr, Inc. (CXM)
Coliseum Acquisition (MITAU)
Upcoming IPO
Soulgate Inc. (SSR)
Bright Health Group Inc. (BHG)
Doximity, Inc. (DOCS)
Miromatrix Medical, Inc (MIRO)
Confluent, Inc. (CFLT)
Monte Rosa Therapeutics Inc. (GLUE)
Amtd Digital, Inc. (HKD)
Unicycive Therapeutics Inc. (UNCY)
Acurx Pharmaceuticals (ACXP)
Mister Car Wash, Inc. (MCW)
Elevation Oncology, Inc. (ELEV)
Alpha Teknova, Inc. (TKNO)
Gh Research Plc (GHRS)
Graphite Bio, Inc. (GRPH)
The Glimpse Group (VRAR)
Integral Ad Science Holding Corp. (IAS)
D-MARKET Electronic Services & Trading (HEPS)
Missfresh Limited (MF)
Dingdong (cayman) Limited (DDL)
Xometry, Inc. (XMTR)
Sentinelone, Inc. (S)
Intapp, Inc. (INTA)
Cvrx, Inc. (CVRX)
Legalzoom.com, Inc. (LZ)
Clear Secure, Inc. (YOU)
Torrid Holdings, Inc. (CURV)
D-market Electronic Services & Trading (HBX)
Evercommerce Inc (EVCM)
Krispy Kreme, Inc. (DNUT)
Priced IPO
Full Truck Alliance Co. Ltd. (YMM)
Century Therapeutics, Inc (IPSC)
Atai Life Sciences B.v. (ATAI)
Femasys (FEMY)
Tremor International Ltd. (TRMR)
Cyteir Therapeutics, Inc. (CYT)
Codex Dna, Inc. (DNAY)
Aihuishou International Co. Ltd. (RERE)
Ambrx Biopharma Inc (AMAM)
iSpecimen (ISPC)
Angel Oak Mortgage, Inc. (AOMR)
Lyell Immunopharma, Inc. (LYEL)
Verve Therapeutics, Inc. (VERV)
Molecular Partners Inc. (MOLN)
Walkme Ltd. (WKME)
Convey Holding Parent, Inc. (CNVY)
Alzamend Neuro (ALZN)
Taskus, Inc. (TASK)
Janux Therapeutics, Inc. (JANX)
Kanzhun Limited (BZ)
More companies

Valneva Se (VALN)

Sector - Healthcare

Price chart

+0.27%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. They take a highly specialized and targeted approach to vaccine development, beginning with the identification of deadly and debilitating infectious diseases that lack a prophylactic vaccine solution and for which there are limited therapeutic treatment options. They then apply their deep understanding of vaccine science, including their expertise across multiple vaccine modalities, as well as their established vaccine development capabilities, to develop prophylactic vaccines to address these diseases. They have leveraged their expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19. They have already successfully licensed and commercialized a portfolio of traveler vaccines, which is composed of IXIARO (also marketed as JESPECT in Australia and New Zealand), indicated for the prevention of Japanese encephalitis in travelers and military personnel, and DUKORAL, indicated for the prevention of cholera and, in Canada, Switzerland, New Zealand and Thailand, prevention of diarrhea caused by enterotoxigenic Escherichia coli, or ETEC, the leading causes of travelers’ diarrhea.
Industry
Pharmaceutical Preparations
CEO CFO
Thomas Lingelbach Franck Grimaud
Employees Founded
640 1999

Contacts

Address: 6 Rue Alain Bombard 44800 Saint-herblain, France

Telephone: +33 2 28 07 37 10

Web page: http://www.valneva.com

IPO information

First Trade Date 5/6/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 3.5
Shares Revised (MM) 2.3
Expected offer amount (MM) $100
Realized offer amount(MM) $60.74

Financial Data (last reporting year)

Market Cap (MM) $1382.21
Revenues (MM) $133.11
Net Income (Loss) (MM) $77.7

Voting

What do you think will happen with the VALN share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: Goldman Sachs

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
Goldman Sachs/ Jefferies/ Guggenheim Securities/ Bryan, Garnier & Co
CO-Managers

Sector: Healthcare

Tweets about $VALN

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats